Titlebook: Biologic Therapy of Leukemia; Matt Kalaycio Book 2003 Springer Science+Business Media New York 2003 antibody.cytokine.cytokines.dendritic

Blandishment

書目名稱Biologic Therapy of Leukemia影響因子(影響力)




書目名稱Biologic Therapy of Leukemia影響因子(影響力)學(xué)科排名




書目名稱Biologic Therapy of Leukemia網(wǎng)絡(luò)公開度




書目名稱Biologic Therapy of Leukemia網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Biologic Therapy of Leukemia被引頻次




書目名稱Biologic Therapy of Leukemia被引頻次學(xué)科排名




書目名稱Biologic Therapy of Leukemia年度引用




書目名稱Biologic Therapy of Leukemia年度引用學(xué)科排名




書目名稱Biologic Therapy of Leukemia讀者反饋




書目名稱Biologic Therapy of Leukemia讀者反饋學(xué)科排名

Thyroxine

Radiolabeled Monoclonal Antibodies-mediated cytotoxicity (ADCC), in which an effector cell expressing an Fc receptor binds to a cell-bound MAb and is triggered to kill the target cell. Examples of antibodies with intrinsic immunologically mediated antitumor activity include the chimeric anti-CD20 antibody rituximab . and the humaniz

CLAN

浮雕寶石

Oligarchy

Tartar

Gudgeon

gorgeous

Franz J. Frei,Thomas Erb,Robert Sümpelmann in their eradication. The . Web site currently lists 596 clinical trials initiated since 1989, including 376 (63%) that are related to the treatment of malignancies, with 2389 patients enrolled in cancer-related gene therapy protocols .. A total of 46 (8%) of all gene therapy trials focus on the tr

leniency

Human Leukemia-Derived Dendritic Cells as Tools for Therapy such as the recently developed tyrosine kinase inhibitor Imatinib Mesylate, may fail to control advanced forms of the target disease .. Additionally, for many human leukemias, no such well-defined genetic background is available at present. Accordingly, efforts to advance the therapy for these diseases must focus on other approaches.

fibroblast

Interleukin-2 Treatment of Acute Leukemia(AML), 60–80% of patients will initially achieve complete remission (CR) but the majority of them will relapse .. Only 10%–30% of patients achieve prolonged leukemia-free survival .. In the case of acute lymphocytic leukemia (ALL), 60–65% of children can achieve long-term survival but only 10–30% of adults survive 5 yr free of recurrence ..